London, July 5, 2021 Ahead of the previously announced spin-off of its On-Highway business and the designation of Gerrit Marx as the Chief Executive Officer,
BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) — Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative
Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company
Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP targets tumor lesions in cancer patients; a new product partnered
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and
Nguyen Hai CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — As part of its commitment to help producers meet the growing demand for animal protein in
Seattle, July 01, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures